Free special edition 2023
Who are we?
INTERNATIONAL
eng l i sh . prescr i re . org
Prescrire is a French non-profit continuing education organisation, committed to better patient care Prescrire International is a monthly journal consisting of selected articles translated from La Revue Prescrire
President of Association Mieux Prescrire: Antoine Grandvuillemin, pharmacist ASSOCIATIONMIEUXPRESCRIRE “Towork, inall independence, infavourof quality healthcare, first and foremost intheinterest ofpatients(...)” (Article 1 of the Association Mieux Prescrire bylaws). Prescrire International is published 11 times a year byAssociation Mieux Prescrire, a non-profit continuing-education organisation (N° 11 711 075) registered under the French lawof 1901. EDITORIALSTAFF Members of the Prescrire Editorial Staff sign a yearly declaration of absence of conflicts of interest, in accordance with Prescrire’s “Non merci...” Charter. Members are free from any interest contrary to Association Mieux Prescrire’s objectives (the Charter and the Declaration are available online at english. prescrire.org). Publishing reliable reviews that are easy to use and adapted to readers’ needs depends upon complex editorial procedures, all initiated and overseen by the members of Prescrire’s Editorial Staff. Members of the Editorial Staffdefine editorial goals. They oversee the literature search, the writing and rewriting of texts, and the review by a panel of outside experts including medical specialists, methodologists, representatives of Prescrire’s subscriber base. They organise internal and external quality control procedures, and edit the final copy. Every draft is submitted, before publication, to a large number of external reviewers. Around 250 people participate in the production and distribution of every issue of La Revue Prescrire , including: - around 150members of the Prescrire team ; - around 100 external reviewers, experts in the subjects discussed and practising healthcare professionals. For each issue, readers are provided with a list of the contributors to that issue.
drugs and therapeutic and diagnostic strategies. Association Mieux Prescrire publishes a monthly journal inFrench, andanedition in English 11 times a year. A non-profit organisation, Prescrire is wholly financed by subscribers, and accepts no advertising or other outside support. Reliable and relevant content Prescrire has the editorial and research capabilities necessary to ensure the accuracy of its reviews. Most of Prescrire’s editors are healthcare professionals, specially trained in Prescrire’s editorial methodsandfreefromconflictsof interest. Exacting quality-control procedures are applied to all editorial content.
The Association Mieux Prescrire (AMP), a non-profit organisation registered under the French law of 1901, manages all of Prescrire’s programmes and publications. TheAMPis structuredsoastobefreeofany influencefrompharmaceutical companies or healthcare institutions. Independent information Prescrire’s purpose is stated in Article 1 of the AMP bylaws: “To work, in all inde- pendence, infavourofqualityhealth-care,first and foremost in the interest ofpatients (...).” Prescrire offers continuing education specifically adaptedtotheneedsofhealth care professionals. Since 1981, Prescrire has provided healthcare professionals – and via them, patients – with the clear, comprehensive and reliable information they need about
Subscribers can download any of the thousands of detailed, fully referenced articles produced by Prescrire’s multidisciplinary team. All are available instantly , via an online table of contents going back to 1992, or via a search function.
SUBSCRIBE NOWFOR FULL ACCESS
TO ONLINE CONTENT
Copyright Prescrire www.prescrire.org Registered address: 83, bd Voltaire 75011 Paris France Tel.: +33 1 49 23 72 80 E-mail: contact@prescrire.org Postal address: Prescrire - 83, bd Voltaire 75558 PARIS CEDEX 11 - FRANCE
Reliable, rigorously independent information, on drugs authorised in Europe. No grants, no advertising. No shareholders, no sponsors. Prescrire is financed by subscribers.
Prescrire is a founder andmember of the International Society of Drug Bulletins (ISBD), a worldwide network of bulletins and journals
NO GRANTS NO ADVERTISING NO CONFLICTS OF INTEREST
on drugs and therapeutics that are financially and intellectually independent of the pharmaceutical industry. The overall aimof ISDB is to encourage and assist the development of independent drug bulletins and to facilitate
cooperation amongst them. Website: www.isdbweb.org
Printed by Bulls Market Group/TPI
Made with FlippingBook - professional solution for displaying marketing and sales documents online